Home > Publications database > Liquid biopsy-based early tumor and minimal residual disease detection : New perspectives for cancer predisposition syndromes > print

001     286602
005     20240229155127.0
024 7 _ |a 10.1515/medgen-2023-2049
|2 doi
024 7 _ |a 0936-5931
|2 ISSN
024 7 _ |a 1863-5490
|2 ISSN
037 _ _ |a DKFZ-2023-02814
082 _ _ |a 610
100 1 _ |a Bohaumilitzky, Lena
|0 P:(DE-He78)a7f54298fcba548e34453b02202e6519
|b 0
|e First author
|u dkfz
245 _ _ |a Liquid biopsy-based early tumor and minimal residual disease detection : New perspectives for cancer predisposition syndromes
260 _ _ |a Berlin
|c 2023
|b de Gruyter
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1703847334_27806
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:F210#LA:F210#
536 _ _ |a 316 - Infektionen, Entzündung und Krebs (POF4-316)
|0 G:(DE-HGF)POF4-316
|c POF4-316
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Gebert, Johannes
|0 P:(DE-He78)c826cd3421c6d05725b35568f80b4c67
|b 1
|u dkfz
700 1 _ |a Doeberitz, Magnus von Knebel
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Kloor, Matthias
|0 P:(DE-He78)028ee60cca729028708496826f077b58
|b 3
|u dkfz
700 1 _ |a Ahadova, Aysel
|0 P:(DE-He78)07eef6d38a91f4642c810745c5bf5000
|b 4
|e Last author
|u dkfz
773 _ _ |a 10.1515/medgen-2023-2049
|g Vol. 35, no. 4, p. 259 - 268
|0 PERI:(DE-600)2163157-8
|n 4
|p 259 - 268
|t Medizinische Genetik
|v 35
|y 2023
|x 0936-5931
909 C O |o oai:inrepo02.dkfz.de:286602
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)a7f54298fcba548e34453b02202e6519
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)c826cd3421c6d05725b35568f80b4c67
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)028ee60cca729028708496826f077b58
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)07eef6d38a91f4642c810745c5bf5000
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-316
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Infektionen, Entzündung und Krebs
|x 0
914 1 _ |y 2023
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2023-10-25
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-25
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-25
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MED GENET-BERLIN : 2022
|d 2023-10-25
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-25
920 2 _ |0 I:(DE-He78)F210-20160331
|k F210
|l KKE Angewandte Tumorbiologie
|x 0
920 1 _ |0 I:(DE-He78)F210-20160331
|k F210
|l KKE Angewandte Tumorbiologie
|x 0
920 0 _ |0 I:(DE-He78)F210-20160331
|k F210
|l KKE Angewandte Tumorbiologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F210-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21